Suppr超能文献

尿激酶受体相关蛋白(uPARAP/endo180):一种与纤溶酶原激活系统相连的新型内化受体。

The urokinase receptor associated protein (uPARAP/endo180): a novel internalization receptor connected to the plasminogen activation system.

作者信息

Engelholm L H, Nielsen B S, Danø K, Behrendt N

机构信息

The Finsen Laboratory, Rigshospitalet, Ø, Copenhagen, Denmark.

出版信息

Trends Cardiovasc Med. 2001 Jan;11(1):7-13. doi: 10.1016/s1050-1738(01)00076-7.

Abstract

The urokinase-mediated plasminogen activation system plays a central role in the extracellular proteolytic degradation reactions in cancer invasion. In this review article we discuss a number of recent findings identifying a new cellular receptor protein, uPARAP, that interacts with components of this proteolytic system. uPARAP is a high molecular weight type-1 membrane protein, belonging to the macrophage mannose receptor protein family. On the surface of certain cells, uPARAP forms a ternary complex with the pro-form of the urokinase-type plasminogen activator (uPA) and its primary receptor (uPAR). While the biological consequences of this reaction have not yet been verified experimentally, a likely event is ligand internalization because uPARAP is a constitutively recycling internalization receptor. uPARAP also binds at least one component, collagen type V, in the extracellular matrix meshwork, pointing to a potential role in proteolytic substrate presentation. Additional ligands have been proposed, including collagenase-3 and glycoproteins capable of interacting with one of the multiple carbohydrate recognition-type domains of uPARAP. In various adult tissues uPARAP is present on fibroblasts, macrophages and a subset of endothelial cells. In fetal tissues the protein has also been demonstrated in certain bone forming regions. Hypotheses on the physiological function of uPARAP include regulatory roles in extracellular proteolysis. This type of function would be likely to direct the local turnover of proteases and their substrate degradation products and thus may add to the complicated interplay between several cell types in governing restricted tissue degradation.

摘要

尿激酶介导的纤溶酶原激活系统在癌症侵袭的细胞外蛋白水解降解反应中起核心作用。在这篇综述文章中,我们讨论了一些最近的研究发现,这些发现鉴定出一种新的细胞受体蛋白——尿激酶型纤溶酶原激活物受体相关蛋白(uPARAP),它与这种蛋白水解系统的成分相互作用。uPARAP是一种高分子量的1型膜蛋白,属于巨噬细胞甘露糖受体蛋白家族。在某些细胞表面,uPARAP与尿激酶型纤溶酶原激活剂(uPA)的前体形式及其主要受体(uPAR)形成三元复合物。虽然这一反应的生物学后果尚未通过实验得到验证,但一个可能的事件是配体内化,因为uPARAP是一种组成型循环内化受体。uPARAP还与细胞外基质网络中的至少一种成分——Ⅴ型胶原结合,这表明它在蛋白水解底物呈递中可能发挥作用。还提出了其他配体,包括胶原酶-3和能够与uPARAP的多个碳水化合物识别型结构域之一相互作用的糖蛋白。在各种成人组织中,uPARAP存在于成纤维细胞、巨噬细胞和一部分内皮细胞上。在胎儿组织中,也已在某些骨形成区域证实了该蛋白的存在。关于uPARAP生理功能的假说包括在细胞外蛋白水解中的调节作用。这种功能可能会指导蛋白酶及其底物降解产物的局部周转,从而可能会增加几种细胞类型在控制有限组织降解过程中的复杂相互作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验